Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CVS Health to Support Researchers Who Stand Up To Cancer with In-Store Fundraising Campaign

Featuring Stand Up To Cancer Ambassador and Award-Winning Actress Tracee Ellis Ross and New PSA Produced in Partnership with Funny Or Die

Funds Raised Will Help Accelerate Innovative Cancer Research

CVS Health (PRNewsFoto/CVS Health)

News provided by

CVS Health

Oct 30, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX

WOONSOCKET, R.I., Oct. 30, 2017 /PRNewswire/ -- CVS Health [NYSE:CVS] today announced its fourth yearly in-store fundraising campaign at CVS Pharmacy locations nationwide will occur October 29 – November 19, to benefit Stand Up To Cancer (SU2C) and its ongoing efforts to accelerate the pace of cancer research. CVS Health colleagues and customers have raised more than $15 million for Stand Up To Cancer since 2014.

Funds raised through November 19 will support cancer research programs that get new therapies to patients quickly and save lives now. CVS Pharmacy customers can support Stand Up To Cancer by making a $1, $3 or larger donation at the register or online at www.StandUpToCancer.org/CVSHealth.

"Just about everyone knows someone battling cancer and it affects our customers, colleagues, and communities every day," said Helena Foulkes, Executive Vice President of CVS Health and President, CVS Pharmacy. "As a purpose-driven company dedicated to helping people on their path to better health, we're proud to support Stand Up To Cancer as they accelerate groundbreaking research to help save more lives."

This year's campaign will be supported by in-store radio and marketing collateral with Stand Up To Cancer ambassador and Golden Globe-winning and Emmy-nominated actress Tracee Ellis Ross of Blackish. It will also include a new public service announcement produced in partnership with the comedy brand Funny Or Die. The PSA features an adolescent boy who humorously struggles to spend the dollar given to him by his grandfather, only to learn that his good fortune can be put to good use when he donates the dollar to SU2C at his local CVS Pharmacy.

"I am honored to help raise awareness and funds for Stand Up To Cancer through CVS Health's fundraising campaign," said Ross. "Cancer has touched so many of our lives, and I hope everyone will join me in helping make more cancer patients into survivors by donating in stores or online."   

Donations made during the campaign will support SU2C's collaborative cancer research model which brings together scientists from different institutions and across multiple disciplines to work together to translate their research from the laboratory to the patient.

The critical funds raised by CVS Pharmacy customers over the past four years have helped SU2C to develop new effective treatments such as the immunotherapy CAR T therapy which was recently recommended for FDA approval for treatment of a type of pediatric leukemia, known as acute lymphoblastic leukemia (ALL). This first success could lead to similar treatments for acute myeloid leukemia (AML) and other cancers. SU2C was an early -- and major -- funder of immunotherapy research and these investments, thanks in part to CVS Pharmacy and their customers, are contributing significantly to advancements in the field of immunotherapy. In addition to the strides in immunotherapy, SU2C has supported developments of treatments that received an FDA "breakthrough therapy" designation for advanced breast cancer as well as an FDA approval for pancreatic cancer. 

"Because of CVS Health's commitment to Stand Up To Cancer, we're able to make progress in increasing treatment options for patients and making advancements in the fight against cancer," said Stand Up To Cancer Co-Founder Sue Schwartz. "We're are inspired by CVS Health's dedication to the health of their customers and are grateful to CVS Health and their customers for helping SU2C achieve our mission of making everyone diagnosed with cancer a survivor."

Additionally, to increase awareness of the critical work being done by SU2C, customers can participate in the Value of a Dollar challenge for a chance to win the Ultimate Hollywood Experience. When visiting at CVS Pharmacy between October 29 and November 19, take a selfie and post on your Instagram and/or Twitter with the hashtag #ValueOfADollar and #Promotion to be entered into the sweepstakes* for a chance to win a trip for two to attend the red carpet world premiere of Jumanji: Welcome to the Jungle (in theaters December 20) and a tour of Sony Pictures Studios. 

CVS Pharmacy has also teamed up with Hallmark this year to debut two new exclusive card collections in-store aimed at supporting hope, health and happiness – Stand Up To Cancer and Laugh for the Health of it, which are available in locations nationwide.

For more information on Stand Up To Cancer, a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization, and to make a donation, please visit www.StandUpToCancer.org/CVSHealth.

About CVS Health 
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com/. 

About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C's scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.

Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, and Kathleen Lobb. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Sung Poblete, PhD, RN, has served as SU2C's president and CEO since 2011.

For more information on Stand Up To Cancer, visit www.StandUpToCancer.org.

*About the Sweepstakes 

NO PURCHASE OR DONATION NECESSARY.  Void where prohibited and outside US.  Must be legal resident of the 50 US (incl. DC) age 18+ (19+ in NE and AL; 21+ in MS) at entry.  Sweepstakes begins 9:00:01 AM ET 10/29/17; ends 11:59:59 PM ET on 11/19/17. To enter, take a selfie at a CVS PharmacyTM and post it with #ValueOfaDollar and #Promotion to your Twitter and/or Instagram account(s).  You will get 1 entry for each post, and may post once per platform per day. You can also enter by emailing [email protected] with subject line "#Valueofadollar Sweepstakes". You will get two entries for every email that you send, and may email once per day.  Maximum 2 entries per day and 22 entries total regardless of method of entry. One winner, chosen at random, will get a trip for winner and guest to the Jumanji® premiere in Los Angeles, CA on December 11, 2017. Total ARV of Prize: [$2,670]. Odds of winning depend on number of entries received.  For complete full rules, see StandUpToCancer.org/Jumanji.  Sponsor: Entertainment Industry Foundation. All rights reserved.

Copyright ©2017 Entertainment Industry Foundation. Entertainment Industry Foundation®, CVS PharmacyTM, Jumanji®, Sony®, and other logos or trademarks listed herein are trademarks of Entertainment Industry Foundation, CVS, or Sony in the U.S. and other countries.  All rights reserved.  Motion Picture Artwork © 2017 Columbia TriStar Marketing Group, Inc. All rights reserved.

Media Contacts:

Mary Gattuso, for CVS Health
1-401-770-9811
[email protected]

Emily Gest, for Stand Up to Cancer
Rubenstein
212 843 8061
[email protected]

SOURCE CVS Health

Related Links

http://www.cvshealth.com

21%

more press release views with 
Request a Demo

Modal title

Also from this source

CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day Event

CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day Event

Today at its 2025 Investor Day, CVS Health® (NYSE: CVS) (the "Company") will launch its strategy to deliver best-in-class execution, transform...

CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States

CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States

CVS Health® (NYSE: CVS) today released its inaugural National Economic Impact Report demonstrating the positive economic impact that the company has...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Retail

Retail

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.